GANGAGEN BIOTECHNOLOGIES
CARB-X to award $2.5 million to GangaGen for developing pneumonia drugKlebsiella pneumoniae presents a serious health challenge around the world and is of increasing concern in low-and-middle-income countries ...
Now smaller firms developing antibiotics but will society, politicians accept high prices?As a woman dies in the US from a superbug infection likely caught in India, four domestic companies are taking up the cudgels in the area o...
Why Indian entrepreneurs are missing at the top in both biotech and consumer tech cos in Silicon ValleyTechnology becomes more and more important as consumer technology companies grow. Facebook and Twitter now use analytics intensely.
Biotech startups turn chary as AstraZeneca shuts R&D unitNearly half a dozen startups trace their roots to the 25-year-old centre that led critical research in areas such as tuberculosis and malar...
Load More